IRIS Accounts Production v25.1.3.33 12215708 director 1.1.24 31.12.24 31.12.24 30/4/2025 false true false false true false Auditors Opinion Ordinary share 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122157082023-12-31122157082024-12-31122157082024-01-012024-12-31122157082022-12-31122157082023-01-012023-12-31122157082023-12-3112215708ns15:EnglandWales2024-01-012024-12-3112215708ns14:PoundSterling2024-01-012024-12-3112215708ns10:Director12024-01-012024-12-3112215708ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3112215708ns10:SmallEntities2024-01-012024-12-3112215708ns10:Audited2024-01-012024-12-3112215708ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3112215708ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3112215708ns10:FullAccounts2024-01-012024-12-3112215708ns10:OrdinaryShareClass12024-01-012024-12-3112215708ns10:CompanySecretary12024-01-012024-12-3112215708ns10:RegisteredOffice2024-01-012024-12-3112215708ns5:CurrentFinancialInstruments2024-12-3112215708ns5:CurrentFinancialInstruments2023-12-3112215708ns5:ShareCapital2024-12-3112215708ns5:ShareCapital2023-12-3112215708ns5:RetainedEarningsAccumulatedLosses2024-12-3112215708ns5:RetainedEarningsAccumulatedLosses2023-12-3112215708ns5:ComputerEquipment2024-01-012024-12-3112215708ns5:ComputerEquipment2023-12-3112215708ns5:ComputerEquipment2024-12-3112215708ns5:ComputerEquipment2023-12-3112215708ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3112215708ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3112215708ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 12215708 (England and Wales)
















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

VANGUARD MEDICAL DEVICES LIMITED

VANGUARD MEDICAL DEVICES LIMITED (REGISTERED NUMBER: 12215708)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


VANGUARD MEDICAL DEVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTOR: Ulrike Marczak





SECRETARY: JTC (UK) Limited





REGISTERED OFFICE: The Scalpel
18th Floor,
52 Lime Street
London
EC3M 7AF





REGISTERED NUMBER: 12215708 (England and Wales)





AUDITORS: Ad Valorem Audit Services Limited
Chartered Certified Accountants & Statutory
Auditors
2 Manor Farm Court
Old Wolverton Road
Old Wolverton
Milton Keynes
Buckinghamshire
MK12 5NN

VANGUARD MEDICAL DEVICES LIMITED (REGISTERED NUMBER: 12215708)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2024

2024 2023
as restated
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 1,228 148

CURRENT ASSETS
Debtors 5 2,478 23,943
Cash at bank 8,128 12,857
10,606 36,800
CREDITORS
Amounts falling due within one year 6 1,519,360 1,495,137
NET CURRENT LIABILITIES (1,508,754 ) (1,458,337 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(1,507,526

)

(1,458,189

)

CAPITAL AND RESERVES
Called up share capital 7 1 1
Retained earnings (1,507,527 ) (1,458,190 )
SHAREHOLDERS' FUNDS (1,507,526 ) (1,458,189 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 April 2025 and were signed by:





Ulrike Marczak - Director


VANGUARD MEDICAL DEVICES LIMITED (REGISTERED NUMBER: 12215708)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

Vanguard Medical Devices Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FOREIGN CURRENCIES
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

VANGUARD MEDICAL DEVICES LIMITED (REGISTERED NUMBER: 12215708)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

GOING CONCERN
At the year end the Company had net liabilities of £1,508,754 and net current liabilities of £1,507,526, of which £1,370,563 related to amounts due to the parent company. The Company is reliant on the parent company to provide funds to ensure that it is able to pay its other liabilities as they fall due. The amount due to the parent company is repayable on demand, however the directors have received assurances from the parent company that this amount will not be demanded and that the parent company will continue to provide sufficient funds to the company to allow it to continue its operations.

The parent company has indicated that it has sufficient resources to support the company in the short term and it expects the company to become cash self-sufficient within 12 months. The directors have therefore concluded that the company is a going concern."

PARENT COMPANY
The immediate parent undertaking of Vanguard Medical Devices LTD is Vanguard AG, a Company incorporated in Germany with registered office at Landsberger Str. 222, 12623 Berlin, Deutschland.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
Cost
At 1 January 2024 889
Additions 1,263
At 31 December 2024 2,152
Depreciation
At 1 January 2024 741
Charge for year 183
At 31 December 2024 924
Net book value
At 31 December 2024 1,228
At 31 December 2023 148

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Other debtors 2,478 23,943

VANGUARD MEDICAL DEVICES LIMITED (REGISTERED NUMBER: 12215708)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Bank loans and overdrafts - 12
Trade creditors 1,885 2,260
Amounts owed to group undertakings 1,370,563 1,379,836
Taxation and social security 78,225 53,549
Other creditors 68,687 59,480
1,519,360 1,495,137

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: as restated
£    £   
1 Ordinary share £1 1 1

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Zubair Arshad (Senior Statutory Auditor)
for and on behalf of Ad Valorem Audit Services Limited

9. RELATED PARTY DISCLOSURES

During the year the company operated loans with its parent company. The amount outstanding and included within creditors at the year end was £1,370,563, (2023 - £1,379,836). Interest is charged on the loan at 2.5%. The loan is repayable on demand.

10. ULTIMATE CONTROLLING PARTY

Mr Thomas Peter Maier is the controlling party.